Rapid detection of viruses among potential applications of research at UC Santa Cruz. In 2010, Ahmet Ali Yanik published his first paper on the rapid detection of Ebola virus using new biosensor technology, he and...
Epidemics like the current Ebola outbreak in West Africa often get started when people make contact with animals carrying infectious diseases, but, paradoxically, a certain amount of human exposure to a virus at its...
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. Researchers at the National Institute of Allergy and...
A new HIV/AIDS vaccine, developed by Chinese scientists, has completed its safety testing stage, the results of which will soon be submitted to the Chinese authorities, experts said during the 2014 National Conference...
Russian scientists are developing a technology to make monoclonal antibodies specific to the Ebola virus. If successful, the resulting medicine could be available as soon as December. Testing points to a positive effect...
Researchers at Cambridge University have effectively ‘barcoded’ the bacteria so that they can see where in the body they go and how they fare against the immune system. Vaccines against Salmonella that use a live, but...
Search for vaccine is often a very expensive business. There has to be a large ready market for pharmaceutical companies to invest their private capital. So, the question is, are drug companies interested in something...
Researchers from the London School of Hygiene & Tropical Medicine and the Stop TB Department at the World Health Organization found that a vaccine given to adolescents and adults in low- and middle-income countries...
Over 3,000 people have died from the Ebola virus in West Africa, according to the World Health Organization. With no signs of the deadly virus slowing down, scientists and pharmaceutical companies are scrambling to find...
Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint...